24 C
Thursday, February 22, 2024
HomeOpinion'Grave doubts about the public benefit of universal vaccination'

Popular Now

‘Grave doubts about the public benefit of universal vaccination’

OPINION: This is an opinion by an anonymous and concerned Daily Telegraph reader. The information was sent by the reader to legacy mainstream media and government COVID propaganda units Stuff.co.nz and NZHerald.co.nz two weeks ago. No reply was given. Daily Telegraph has agreed to publish it.

I find it rather interesting that the media can report a SUSPECTED (but not confirmed) COVID deaths but they fail to speak about any of the Pfizer deaths, all 94 of them as reported to Medsafe as suspected due to vaccine, or the 1,000 serious adverse reactions as advised by ACC today. These numbers are expected to double.

Grave doubts about COVID vax opinion

The mainstream media (MSM) even state in these articles that the cause of death is NOT confirmed by the ministry of health, yet their headlines suggest otherwise. If you can’t report Pfizer suspected deaths then isn’t this double standards?

Isn’t this Installing unnecessary fear in our already crippled nation?

If you don’t know what I’m talking about (which I doubt) here is a friendly reminder.

  • Casey’s story
  • ACC NZ Staff member speaks out about adverse reactions and deaths post vaccine
  • Medsafe vaccine reporting

I have many more examples. Let me know if any of you have the guts to speak about what’s really going on in NZ.

A Stuff.co.nz reporter wrote this article back in 2019. What happened to this kind of honest media? Let’s talk about this.

I also want to see the following questions reported on:

  • Daily percentage of covid positive cases reported as vaccinated or unvaccinated
  • Hospital cases and ICU reporting on why exactly are the patients there? Do they have COVID only? Do they have other medical issues, but also have COVID? Are they vaccinated or unvaccinated?
  • Serious adverse reactions and deaths post Pfizer vaccine from around the world and NZ
  • Unlinked cases. Why do we suddenly (since we have started the vaccination rollout) have unlinked cases? Are they vaccinated or unvaccinated? Where do the unlinked cases come from? Last year all cases were epidemiologically linked to clusters. Why the change, did Delta fall from the sky?
  • The rest home in Auckland where all 20 COVID positive cases are vaccinated. No visits to rest homes are allowed in level 3 and 4, so where did this actually come from? And if the vaccine works so well then why are two in hospital? How about some research and reporting from overseas studies (all creditable by the way). if I can find this factual, documented information surely the MSM can too.

Why is Ivermectin banned in New Zealand for treatment of COVID when it is very successful overseas and its even an approved treatment as listed in the NIH.govt web site with case studies available?

Why aren’t we trialling Ivermectin in New Zealand?

Why was rapid antigen testing banned in New Zealand in April 2020? Makes you wonder why.

Why are we mandating a vaccine that

  • (a) doesn’t prevent transmission, and
  • (b) doesn’t prevent hospitalisations and deaths

when its been proven around the world that fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts?

Why are we rolling out vaccine passports and excluding people from society and the ability to work when there is absolutely no reason to, apart from the MSM propaganda rubbish brainwashing society. You can find proof this in the Lancet Journal.

On 2 November 2021 the British Medical Journal (The BMJ) published an article called COVID-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial.

What about an article in the UK MSM recently, in The Guardian.

Published in the Office for National Statistics 2 November: Deaths by vaccination status, England – UK Vaccines DEATH TOLL RISING to 166,859.

These credible sources completely contradict any reason to mandate the jab or to exclude the unjabbed from society. Why doesn’t the MSM in New Zealand talk about that!

How about this study from the US National Library of Medicine, National institutes of Health: Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States (nih.gov)?

At the country-level, there appears to be no discernable relationship between the percentage of population fully vaccinated and new COVID-19 cases in the last 7 days. In fact, the trend line suggests a marginally positive association such that countries with higher percentage of population fully vaccinated have higher COVID-19 cases per 1 million people.

In a hospital outbreak investigation in Israel, Shitrit et al. observed “high transmissibility of the SARS-CoV-2 Delta variant among twice vaccinated and masked individuals.” They added that “this suggests some waning of immunity, albeit still providing protection for individuals without comorbidities.”

Reporting on a nosocomial hospital outbreak in Finland, Hetemäli et al. observed that “both symptomatic and asymptomatic infections were found among vaccinated health care workers, and secondary transmission occurred from those with symptomatic infections despite use of personal protective equipment.”

In Barnstable, Massachusetts, Brown et al found that among 469 cases of COVID-19, 74% were fully vaccinated, and that “the vaccinated had on average more virus in their nose than the unvaccinated who were infected.”

From Wisconsin, Riemersma et al. reported that vaccinated individuals who get infected with the Delta variant can transmit SARS-CoV-2 to others. They found an elevated viral load in the unvaccinated and vaccinated symptomatic persons (68% and 69% respectively, 158/232 and 156/225). Moreover, in the asymptomatic persons, they uncovered elevated viral loads (29% and 82% respectively) in the unvaccinated and the vaccinated respectively. This suggests that the vaccinated can be infected, harbor, cultivate, and transmit the virus readily and unknowingly.

In a study from Qatar, Chemaitelly et al. reported vaccine efficacy (Pfizer) against severe and fatal disease, with efficacy in the 85-95% range at least until 24 weeks after the second dose. As a contrast, the efficacy against infection waned down to around 30% at 15-19 weeks after the second dose.

Riemersma et al. found “no difference in viral loads when comparing unvaccinated individuals to those who have vaccine “breakthrough” infections. Furthermore, individuals with vaccine breakthrough infections frequently test positive with viral loads consistent with the ability to shed infectious viruses.” Results indicate that “if vaccinated individuals become infected with the delta variant, they may be sources of SARS-CoV-2 transmission to others.

Ignoring the risk of infection, given that someone was infected, Acharya et al. found “no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta.”

Suthar et al. noted that “Our data demonstrate a substantial waning of antibody responses and T cell immunity to SARS-CoV-2 and its variants, at 6 months following the second immunization with the BNT162b2 vaccine.”

In a study from Umeå University in Sweden, Nordström et al. observed that “vaccine effectiveness of BNT162b2 against infection waned progressively from 92% (95% CI, 92-93, P<0·001) at day 15-30 to 47% (95% CI, 39-55, P<0·001) at day 121-180, and from day 211 and onwards no effectiveness could be detected (23%; 95% CI, -2-41, P=0·07).”

Goldberg et al. (BNT162b2 Vaccine in Israel) reported that “immunity against the delta variant of SARS-CoV-2 waned in all age groups a few months after receipt of the second dose of vaccine.”

Keehner et al. in NEJM, has recently reported on the resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. Vaccination with mRNA vaccines began in mid-December 2020; by March, 76% of the workforce had been fully vaccinated, and by July, the percentage had risen to 87%. Infections had decreased dramatically by early February 2021…”coincident with the end of California’s mask mandate on June 15 and the rapid dominance of the B.1.617.2 (delta) variant that first emerged in mid-April and accounted for over 95% of UCSDH isolates by the end of July, infections increased rapidly, including cases among fully vaccinated persons…researchers reported that the “dramatic change in vaccine effectiveness from June to July is likely to be due to both the emergence of the delta variant and waning immunity over time.”

What these studies show is that vaccines are important to reduce severe disease and death, but unable to prevent the disease from spreading and eventually from infecting most of us. That is, while the vaccines provide individual benefits to the vaccinee, and especially to older high-risk people, the public benefit of universal vaccination is in grave doubt.

As such, COVID vaccines should not be expected to contribute to eliminating the communal spread of the virus or the reaching of herd immunity.

This unravels the rationale for vaccine mandates and passports.

The statements, views and opinions expressed in this column are solely those of the author and do not necessarily represent those of dailytelegraph.co.nz.

Promoted Content

No login required to comment. Name, email and web site fields are optional. Please keep comments respectful, civil and constructive. Moderation times can vary from a few minutes to a few hours. Comments may also be scanned periodically by Artificial Intelligence to eliminate trolls and spam.


  1. Our Government is failing to keep the public informed. All sources:
    RELEASE: OCTOBER 27, 2021


    RELEASE: MARCH 9, 2021



    Specifically Page 15 and Page 17

    Page 15
    No mRNA immunotherapy has been approved, and none may ever be approved. mRNA drug development has substantial clinical development and regulatory risks due to the novel and unprecedented nature of this new category of therapeutics.

    Page 17
    In addition, even if we successfully advance one of our product candidates into and through clinical trials, such trials will likely only include a limited number of subjects and limited duration of exposure to our product candidates. As a result, we cannot be assured that adverse effects of our product candidates will not be uncovered when a significantly larger number of patients are exposed to the product candidate. Further, any clinical trials may not be sufficient to determine the effect and safety consequences of taking our product candidates over a multi-year period.


Please enter your comment!
Please enter your name here



overcast clouds
21.8 ° C
23.3 °
21.8 °
46 %
88 %
21 °
18 °
18 °
18 °
18 °

-- Free Ad --